{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-021377","form_type":"8-K","ticker":"BLFS","cik":"0000834365","company_name":"BIOLIFE SOLUTIONS INC","filed_at":"2022-08-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.264338+00:00","generated_at":"2026-06-23T21:11:45.423378+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"BioLife Solutions appoints Timothy L. Moore to board of directors effective Sept 1, 2022","bullets":["Moore brings 30+ years biopharma ops experience; served as EVP Technical Ops at Kite Pharma (Gilead) and head of Genentech biologics ops.","Moore also serves on Cerus Corporation (CERS) board.","Appointed to Compensation Committee and Nominating and Governance Committee.","Board expands to six members; Moore qualifies as independent under Nasdaq rules.","No related-party transactions requiring disclosure; compensation same as other non-employee directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-021377","json":"https://secwatch.observer/filing/0001437749-22-021377.json","markdown":"https://secwatch.observer/filing/0001437749-22-021377.md","text":"https://secwatch.observer/filing/0001437749-22-021377.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/834365/000143774922021377/0001437749-22-021377-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/834365/000143774922021377/bioli20220825_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T21:11:45.423378+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"78a39f5962","claim":"Tim Moore was appointed as Director at BIOLIFE SOLUTIONS INC.","evidence_excerpt":"Effective September 1, 2022, the board of directors (the “Board”) of BioLife Solutions, Inc. (the “Company”) appointed Tim Moore to the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/834365/000143774922021377/0001437749-22-021377-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}